Batten Disease Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: BD83F695FC5EEN
Market Monitor Global

Abstracts

Batten disease is inherited disorder of the nervous system which begins in childhood.It is also called as neuronal ceroid lipofuscinoses (or NCLs). Batten Disease Treatment is the treatment of this type of disease.

This report contains market size and forecasts of Batten Disease Treatment in Global, including the following market information:

Global Batten Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Batten Disease Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Occupational Therapies Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Batten Disease Treatment include BioMarin Pharmaceuticals, Seneb BioSciences, Inc., ReGenX Biosciences LLC, Amicus Therapeutics, Ionis Pharmaceuticals, Inc. and Celenex, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Batten Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Batten Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Batten Disease Treatment Market Segment Percentages, by Type, 2021 (%)

• Occupational Therapies
• Physical Therapies

Global Batten Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Batten Disease Treatment Market Segment Percentages, by Application, 2021 (%)

• Infantile NCL
• Late Infantile NCL
• Juvenile NCL
• Adult NCL

Global Batten Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Batten Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Batten Disease Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Batten Disease Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• BioMarin Pharmaceuticals
• Seneb BioSciences, Inc.
• ReGenX Biosciences LLC
• Amicus Therapeutics
• Ionis Pharmaceuticals, Inc.
• Celenex, Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Batten Disease Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Batten Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BATTEN DISEASE TREATMENT OVERALL MARKET SIZE

2.1 Global Batten Disease Treatment Market Size: 2021 VS 2028
2.2 Global Batten Disease Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Batten Disease Treatment Players in Global Market
3.2 Top Global Batten Disease Treatment Companies Ranked by Revenue
3.3 Global Batten Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Batten Disease Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Batten Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Batten Disease Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Batten Disease Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Batten Disease Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Batten Disease Treatment Market Size Markets, 2021 & 2028
  4.1.2 Occupational Therapies
  4.1.3 Physical Therapies
4.2 By Type - Global Batten Disease Treatment Revenue & Forecasts
  4.2.1 By Type - Global Batten Disease Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Batten Disease Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Batten Disease Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Batten Disease Treatment Market Size, 2021 & 2028
  5.1.2 Infantile NCL
  5.1.3 Late Infantile NCL
  5.1.4 Juvenile NCL
  5.1.5 Adult NCL
5.2 By Application - Global Batten Disease Treatment Revenue & Forecasts
  5.2.1 By Application - Global Batten Disease Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Batten Disease Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Batten Disease Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Batten Disease Treatment Market Size, 2021 & 2028
6.2 By Region - Global Batten Disease Treatment Revenue & Forecasts
  6.2.1 By Region - Global Batten Disease Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Batten Disease Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Batten Disease Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Batten Disease Treatment Revenue, 2017-2028
  6.3.2 US Batten Disease Treatment Market Size, 2017-2028
  6.3.3 Canada Batten Disease Treatment Market Size, 2017-2028
  6.3.4 Mexico Batten Disease Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Batten Disease Treatment Revenue, 2017-2028
  6.4.2 Germany Batten Disease Treatment Market Size, 2017-2028
  6.4.3 France Batten Disease Treatment Market Size, 2017-2028
  6.4.4 U.K. Batten Disease Treatment Market Size, 2017-2028
  6.4.5 Italy Batten Disease Treatment Market Size, 2017-2028
  6.4.6 Russia Batten Disease Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Batten Disease Treatment Market Size, 2017-2028
  6.4.8 Benelux Batten Disease Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Batten Disease Treatment Revenue, 2017-2028
  6.5.2 China Batten Disease Treatment Market Size, 2017-2028
  6.5.3 Japan Batten Disease Treatment Market Size, 2017-2028
  6.5.4 South Korea Batten Disease Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Batten Disease Treatment Market Size, 2017-2028
  6.5.6 India Batten Disease Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Batten Disease Treatment Revenue, 2017-2028
  6.6.2 Brazil Batten Disease Treatment Market Size, 2017-2028
  6.6.3 Argentina Batten Disease Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Batten Disease Treatment Revenue, 2017-2028
  6.7.2 Turkey Batten Disease Treatment Market Size, 2017-2028
  6.7.3 Israel Batten Disease Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Batten Disease Treatment Market Size, 2017-2028
  6.7.5 UAE Batten Disease Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 BioMarin Pharmaceuticals
  7.1.1 BioMarin Pharmaceuticals Corporate Summary
  7.1.2 BioMarin Pharmaceuticals Business Overview
  7.1.3 BioMarin Pharmaceuticals Batten Disease Treatment Major Product Offerings
  7.1.4 BioMarin Pharmaceuticals Batten Disease Treatment Revenue in Global Market (2017-2022)
  7.1.5 BioMarin Pharmaceuticals Key News
7.2 Seneb BioSciences, Inc.
  7.2.1 Seneb BioSciences, Inc. Corporate Summary
  7.2.2 Seneb BioSciences, Inc. Business Overview
  7.2.3 Seneb BioSciences, Inc. Batten Disease Treatment Major Product Offerings
  7.2.4 Seneb BioSciences, Inc. Batten Disease Treatment Revenue in Global Market (2017-2022)
  7.2.5 Seneb BioSciences, Inc. Key News
7.3 ReGenX Biosciences LLC
  7.3.1 ReGenX Biosciences LLC Corporate Summary
  7.3.2 ReGenX Biosciences LLC Business Overview
  7.3.3 ReGenX Biosciences LLC Batten Disease Treatment Major Product Offerings
  7.3.4 ReGenX Biosciences LLC Batten Disease Treatment Revenue in Global Market (2017-2022)
  7.3.5 ReGenX Biosciences LLC Key News
7.4 Amicus Therapeutics
  7.4.1 Amicus Therapeutics Corporate Summary
  7.4.2 Amicus Therapeutics Business Overview
  7.4.3 Amicus Therapeutics Batten Disease Treatment Major Product Offerings
  7.4.4 Amicus Therapeutics Batten Disease Treatment Revenue in Global Market (2017-2022)
  7.4.5 Amicus Therapeutics Key News
7.5 Ionis Pharmaceuticals, Inc.
  7.5.1 Ionis Pharmaceuticals, Inc. Corporate Summary
  7.5.2 Ionis Pharmaceuticals, Inc. Business Overview
  7.5.3 Ionis Pharmaceuticals, Inc. Batten Disease Treatment Major Product Offerings
  7.5.4 Ionis Pharmaceuticals, Inc. Batten Disease Treatment Revenue in Global Market (2017-2022)
  7.5.5 Ionis Pharmaceuticals, Inc. Key News
7.6 Celenex, Inc.
  7.6.1 Celenex, Inc. Corporate Summary
  7.6.2 Celenex, Inc. Business Overview
  7.6.3 Celenex, Inc. Batten Disease Treatment Major Product Offerings
  7.6.4 Celenex, Inc. Batten Disease Treatment Revenue in Global Market (2017-2022)
  7.6.5 Celenex, Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Batten Disease Treatment Market Opportunities & Trends in Global Market
Table 2. Batten Disease Treatment Market Drivers in Global Market
Table 3. Batten Disease Treatment Market Restraints in Global Market
Table 4. Key Players of Batten Disease Treatment in Global Market
Table 5. Top Batten Disease Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Batten Disease Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Batten Disease Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Batten Disease Treatment Product Type
Table 9. List of Global Tier 1 Batten Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Batten Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Batten Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Batten Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Batten Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Batten Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Batten Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Batten Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Batten Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Batten Disease Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Batten Disease Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Batten Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Batten Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Batten Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Batten Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Batten Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Batten Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Batten Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Batten Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Batten Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Batten Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 30. BioMarin Pharmaceuticals Corporate Summary
Table 31. BioMarin Pharmaceuticals Batten Disease Treatment Product Offerings
Table 32. BioMarin Pharmaceuticals Batten Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Seneb BioSciences, Inc. Corporate Summary
Table 34. Seneb BioSciences, Inc. Batten Disease Treatment Product Offerings
Table 35. Seneb BioSciences, Inc. Batten Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 36. ReGenX Biosciences LLC Corporate Summary
Table 37. ReGenX Biosciences LLC Batten Disease Treatment Product Offerings
Table 38. ReGenX Biosciences LLC Batten Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Amicus Therapeutics Corporate Summary
Table 40. Amicus Therapeutics Batten Disease Treatment Product Offerings
Table 41. Amicus Therapeutics Batten Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Ionis Pharmaceuticals, Inc. Corporate Summary
Table 43. Ionis Pharmaceuticals, Inc. Batten Disease Treatment Product Offerings
Table 44. Ionis Pharmaceuticals, Inc. Batten Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Celenex, Inc. Corporate Summary
Table 46. Celenex, Inc. Batten Disease Treatment Product Offerings
Table 47. Celenex, Inc. Batten Disease Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Batten Disease Treatment Segment by Type in 2021
Figure 2. Batten Disease Treatment Segment by Application in 2021
Figure 3. Global Batten Disease Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Batten Disease Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Batten Disease Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Batten Disease Treatment Revenue in 2021
Figure 8. By Type - Global Batten Disease Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Batten Disease Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Batten Disease Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Batten Disease Treatment Revenue Market Share, 2017-2028
Figure 12. US Batten Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Batten Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Batten Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Batten Disease Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Batten Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Batten Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Batten Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Batten Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Batten Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Batten Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Batten Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Batten Disease Treatment Revenue Market Share, 2017-2028
Figure 24. China Batten Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Batten Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Batten Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Batten Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Batten Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Batten Disease Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Batten Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Batten Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Batten Disease Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Batten Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Batten Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Batten Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Batten Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. BioMarin Pharmaceuticals Batten Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Seneb BioSciences, Inc. Batten Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. ReGenX Biosciences LLC Batten Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Amicus Therapeutics Batten Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Ionis Pharmaceuticals, Inc. Batten Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Celenex, Inc. Batten Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)